CNS pipeline · person
Justin Gover, MBA
Director of Xenon Pharmaceuticals since August 2023 and a member of the Audit Committee. He was founding CEO of GW Pharmaceuticals (1999-2021), where he led the development and commercialization of Epidiolex before the company's $7.2 billion sale to Jazz Pharmaceuticals. He holds an M.B.A. from INSEAD.
- 2 companies
Courtesy COMPASS Pathways
Current roles
- COMPASS Pathways plcIndependent Director · Board2025–present
- Xenon Pharmaceuticals Inc.Director · Board
Appears with
People sharing a company with Justin.
- Andrea DiFabio · Xenon Pharmaceuticals Inc.
- Christopher Kenney · Xenon Pharmaceuticals Inc.
- Daphne Karydas · COMPASS Pathways plc
- Darren Cline · Xenon Pharmaceuticals Inc.
- David Norton · COMPASS Pathways plc
- Dawn Svoronos · Xenon Pharmaceuticals Inc.
- Ekaterina Malievskaia · COMPASS Pathways plc
- Elizabeth Garofalo · Xenon Pharmaceuticals Inc.
- Gary Patou · Xenon Pharmaceuticals Inc.
- George Goldsmith · COMPASS Pathways plc
- Gillian Cannon · Xenon Pharmaceuticals Inc.
- Gino Santini · COMPASS Pathways plc
- Guy Goodwin · COMPASS Pathways plc
- Ian Mortimer · Xenon Pharmaceuticals Inc.
- James Empfield · Xenon Pharmaceuticals Inc.
- Jeffrey Jonas · COMPASS Pathways plc
- Kabir Nath · COMPASS Pathways plc
- Kathleen Tregoning · COMPASS Pathways plc
- Lars Christian Wilde · COMPASS Pathways plc
- Lori Englebert · COMPASS Pathways plc
- Matthew D. Ronsheim · Xenon Pharmaceuticals Inc.
- Michael Gold · COMPASS Pathways plc
- Michael Hayden · Xenon Pharmaceuticals Inc.
- Patrick Machado · Xenon Pharmaceuticals Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.